Oroxylin A suppressed colorectal cancer metastasis by inhibiting the activation of the TGF-β/SMAD signal pathway

Abstract Metastatic colorectal cancer continues to have a high fatality rate, with approximately only 14% of patients surviving more than 5 years. To improve the survival rate of these patients, the development of new therapeutic drugs is a priority. In this study, we investigated the effects of Oro...

Olles dieđut

Bibliográfalaš dieđut

Váldodahkkit:	Ji-Ping Cao, Yang Yan, Xin-Shuai Li, Long-Xun Zhu, Rui-Kun Hu, Pan-Feng Feng
Materiálatiipa:	Artigo
Giella:	Inglês
Almmustuhtton:	Nature Portfolio 2024-10-01
Ráidu:	Scientific Reports
Fáttát:	Colorectal cancer Oroxylin A Molecular docking Metastasis EMT TGFβ-smad signalling pathway
Liŋkkat:	https://doi.org/10.1038/s41598-024-75457-3
Fáddágilkorat:	Lasit fáddágilkoriid Eai fáddágilkorat, Lasit vuosttaš fáddágilkora!